Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00655083 · ClinicalTrials.gov registry record · Phase 1
A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants
A Phase 1 study, sponsored by Menarini Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00655083 is a Phase 1 study that has completed, run by Menarini Group. The registered enrollment target is 21 participants.
The verdict
NCT00655083, a Phase 1 study, has completed, sponsored by Menarini Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the gastrointestinal absorption of nepadutant after single dose as oral solution (and the effect of age on its oral absorption) in infants. Oral absorption is evaluated through the drug recovery in urine.
Interventions
- DRUG Nepadutant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2008-03 |
| Est. Completion | 2009-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00655083
The ClinicalTrials.gov registry entry for NCT00655083 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Menarini Group, which has 9 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nepadutant is the first listed.
NCT00655083 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00655083 about?
NCT00655083 is a clinical study titled "A Phase I Study to Evaluate the Oral Absorption of Nepadutant in Infants". The purpose of the study is to evaluate the gastrointestinal absorption of nepadutant after single dose as oral solution (and the effect of age on its oral absorption) in infants. Oral absorption is evaluated through the drug recovery in urine.
What is the current status of trial NCT00655083?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2008-03. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00655083?
The interventions under investigation include: Nepadutant (DRUG).
Who is sponsoring clinical trial NCT00655083?
This trial is sponsored by Menarini Group, which has 9 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.